-
- Home
-
Find Data
-
Study Advanced Search
Use the advanced search to locate studies through a variety of search fields.
-
Pre-Clinical Publications
Use this to find citations from pre-clinical research with a GSK author.
-
Regulatory Overview Documents
Use this to browse additional product-related information.
-
Study Advanced Search
- Patient Level Data
- Products
- Metrics
- Research
- Contact GSK
Back to Search | |
Study ID |
112264 |
Clinical Study ID |
NOG112264 |
Study Title | Study NOG112264, a Phase II Study of Ozanezumab (GSK1223249) versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis |
Clinicaltrials.gov Identifier | NCT01753076 |
Sponsor | GlaxoSmithKline |
Collaborators | N/A |
Phase | Phase 2 |
Study Recruitment Status | Completed |
Generic Name | GSK1223249 |
Trade Name | GSK1223249; ozanezumab |
Study Indication | Amyotrophic Lateral Sclerosis |
First Received | Last Updated | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec 17, 2012 | Nov 27, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Document Title | First Received | Last Updated |
---|---|---|
Sep 16, 2015 | Sep 16, 2015 |
Document Title | First Received | Last Updated |
---|---|---|
Feb 09, 2017 | Feb 09, 2017 |
|
Location Name | Status | ||||||
---|---|---|---|---|---|---|---|
|
|||||||
Australia | |||||||
GSK Investigational Site Australia, New South Wales, Randwick, 2031 Matthew Kiernan, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Australia, Queensland, Herston, 4029 Robert Henderson, Principal Investigator |
COMPLETED | ||||||
Belgium | |||||||
GSK Investigational Site Belgium, Leuven, 3000 Wim Robberecht, Principal Investigator |
COMPLETED | ||||||
Canada | |||||||
GSK Investigational Site Canada, Alberta, Calgary, T3M 1M4 |
COMPLETED | ||||||
GSK Investigational Site Canada, Ontario, London, N6A 5A5 Christen Shoesmith, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Canada, Ontario, Toronto, M4N 3M5 Lorne Zinman, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Canada, Québec, Montreal, H2L 4M1 Stephan Botez, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Canada, Québec, Montreal, H3A 2B4 Angela L Genge, Principal Investigator |
COMPLETED | ||||||
France | |||||||
GSK Investigational Site France, Lille cedex, 59037 Alain Destée, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site France, Limoges cedex, 87042 Philippe Couratier, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site France, Montpellier cedex 5, 34295 William Camu, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site France, Nice cedex 3, 06202 Claude Desnuelle, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site France, Paris cedex 13, 75651 Vincent Meininger, Principal Investigator |
COMPLETED | ||||||
Germany | |||||||
GSK Investigational Site Germany, Baden-Wuerttemberg, Ulm, 89081 Albert Christian Ludolph, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Germany, Bayern, Muenchen, 81675 Andrea Winkler, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Germany, Berlin, Berlin, 13353 Thomas Meyer, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Germany, Niedersachsen, Hannover, 30625 Susanne Petri, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Germany, Nordrhein-Westfalen, Bochum, 44789 Torsten Grehl, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Germany, Thueringen, Jena, 07747 Julian Grosskreutz, Principal Investigator |
COMPLETED | ||||||
Italy | |||||||
GSK Investigational Site Italy, Piemonte, Torino, 10126 Adriano Chiò, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Italy, Veneto, Verona, 37134 Stefano S Milleri, Principal Investigator |
COMPLETED | ||||||
Japan | |||||||
GSK Investigational Site Japan, Kanagawa, 252-0380 Kazutoshi Nishiyama, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Japan, Miyagi, 980-8574 Hitoshi Warita, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Japan, Osaka, 560-8552 Harutoshi Fujimura, Principal Investigator |
COMPLETED | ||||||
Korea, Republic of | |||||||
GSK Investigational Site Korea, Republic of, Seoul, 133-792 Seung Hyun Kim, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Korea, Republic of, Seoul, 136-705 Byung-Jo Kim, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site Korea, Republic of, Seoul, 110-744 Kwang-Woo Lee, Principal Investigator |
COMPLETED | ||||||
Netherlands | |||||||
GSK Investigational Site Netherlands, UTRECHT, 3584 CX Leonard H. van den Berg, Principal Investigator |
COMPLETED | ||||||
United Kingdom | |||||||
GSK Investigational Site United Kingdom, Brighton, BN2 5BE Nigel Leigh, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site United Kingdom, Edgbaston,, B15 2TT Karen E Morrison, Principal Investigator |
COMPLETED | ||||||
GSK Investigational Site United Kingdom, Lancashire, Preston, PR2 9HT Tahir Majeed, Principal Investigator |
COMPLETED | ||||||
United States | |||||||
Massachusetts | |||||||
GSK Investigational Site United States, Massachusetts, Boston, 02114 James Berry, Principal Investigator |
COMPLETED | ||||||
Michigan | |||||||
GSK Investigational Site United States, Michigan, Grand Rapids, 49503 Herman C Sullivan, Principal Investigator |
COMPLETED | ||||||
New York | |||||||
GSK Investigational Site United States, New York, Syracuse, 13210 Anuradha K Duleep, Principal Investigator |
COMPLETED | ||||||
Ohio | |||||||
GSK Investigational Site United States, Ohio, Columbus, 43210 Stephen J Kolb, Principal Investigator |
COMPLETED |
Quick Search
Useful Links
For more information on this register please email GSKClinicalSupportHD@gsk.com
GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.
IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).
This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.
EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.